Ovarian Clear Cell Carcinoma: Genomic Characterization, Pathogenesis and Targeted Therapy.

Area of Science:

• Oncology
• Gynecologic Oncology
• Molecular Pathology

Background:

• Ovarian clear cell carcinomas (OCCCs) are a distinct subtype of ovarian cancer originating from endometriosis.
• These tumors exhibit aggressive behavior, chemoresistance, and poor patient outcomes.
• The precise mechanisms driving malignant transformation from endometriosis to OCCCs are not fully understood.

Purpose of the Study:

• To comprehensively review the molecular mechanisms of malignant transformation in OCCCs.
• To elucidate the genomic characteristics and drug resistance pathways in OCCCs.
• To explore potential targeted therapy strategies for advanced OCCCs.

Main Methods:

• Literature review of existing research on OCCCs.
• Analysis of molecular pathogenesis, genomic data, and drug resistance mechanisms.
• Synthesis of information on targeted therapeutic approaches.

Main Results:

• OCCCs possess unique molecular and genomic profiles.
• Endometriosis is the established precursor, but transformation pathways require further study.
• Current chemotherapy options show limited efficacy, highlighting the need for novel treatments.

Conclusions:

• Elucidating OCCC pathogenesis is crucial for improving clinical management.
• Targeted therapies hold promise for overcoming drug resistance in advanced OCCCs.
• Further research into OCCC molecular mechanisms can guide future treatment strategies.